An upcoming clinical trial will test whether empagliflozin might be able to improve heart health in pulmonary arterial ...

has approved Boehringer Ingelheim’s anti-diabetic drug for the treatment of chronic kidney disease (CKD) in India. According to the company’s statement, Jardiance (empagliflozin) 10mg tablets ...

The Food and Drug Administration (FDA ... and 25 mg Farxiga comes in the following tablet strengths: 5 mg and 10 mg Jardiance ...

Department of Metabolism & Experimental Therapeutics, Division of Medicine, University College London, London, United Kingdom Could empagliflozin be another example of successful drug repurposing?